Over 10 years we help companies reach their financial and branding goals. Engitech is a values-driven technology agency dedicated.

Gallery

Contacts

411 University St, Seattle, USA

+1 -800-456-478-23

Events

Myeloid Therapeutics to Participate in Upcoming Investor Conferences

CAMBRIDGE, Mass., August 29, 2024 /PRNewswire/ — Myeloid Therapeutics, Inc. (“Myeloid”), a clinical-stage immunology company advancing RNA therapeutics to conquer cancer, announced today its participation in the following investor conferences: 22nd Annual Morgan Stanley Healthcare Conference, September 4-6, 2024, in New York, NY Wells Fargo Annual Healthcare Conference, September 4-6, 2024, in Boston, MA Chardan’s […]

Events

Myeloid Therapeutics to Participate in Barclays Biotech: 1×1 Private Company Symposium

CAMBRIDGE, Mass., August 1, 2024 /PRNewswire/ — Myeloid Therapeutics, Inc. (“Myeloid”), a clinical-stage immunology company advancing RNA therapeutics to conquer cancer, announced today its participation in the Barclays Biotech: 1×1 Private Company Symposium on Wednesday, August 7, 2024. This event is being held in a virtual format during which Company management will participate in one-on-one […]

Events

Myeloid Therapeutics to Participate in the Jefferies Healthcare Conference Private Biotech Day

CAMBRIDGE, Mass, May 29, 2024 – Myeloid Therapeutics, Inc. (“Myeloid”), a clinical stage immunology company, announced today that it will participate in the Jefferies Healthcare Conference Private Biotech Day, taking place June 4th, 2024, in New York. Company management will be conducting one-on-one meetings with investors at the conference. About Myeloid Therapeutics Myeloid Therapeutics is […]

Events

Myeloid Therapeutics to Participate in Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit

CAMBRIDGE, Mass, April 15, 2024 – Myeloid Therapeutics, Inc. (“Myeloid”), a clinical stage biotechnology company advancing RNA immunotherapies to conquer cancer, today announced its participation at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit, taking place virtually April 29-30. Daniel Getts, Ph.D., Chief Executive Officer of Myeloid, will participate in a fireside chat […]

Events

Myeloid Therapeutics to Showcase In Vivo CAR Data and its Diverse mRNA Platform at AACR

Presented data support the ongoing clinical assessment of MT-302, the world’s first in vivo mRNA CAR drug development candidate Additional updates highlight Myeloid’s pioneering work, including a set of novel mRNA CAR constructs for in vivo programming of additional immune cell subsets, including NK and T cells CAMBRIDGE, Mass, April 4, 2024 – Myeloid Therapeutics, […]

Events

Myeloid Therapeutics to Provide Updates on its RNA Immunotherapies at Multiple Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2024

CAMBRIDGE, Mass, March 5, 2024 – Myeloid Therapeutics, Inc. (“Myeloid”), a clinical stage immunology company, today announced it will be providing updates on its RNA immunotherapies at multiple presentations at the American Association for Cancer Research (AACR) Annual Meeting taking place April 5-10, 2024, at the San Diego Convention Center. Details follow: Title: In vivo programming […]

Events

Myeloid Therapeutics to Participate at Upcoming Investor Conferences

CAMBRIDGE, Mass, October 2, 2023 – Myeloid Therapeutics, Inc. (“Myeloid”), a clinical stage mRNA-immunotherapy company, today announced that it will participate in the following investor conferences: Chardan’s 7th Annual Genetic Medicines Conference, taking place October 2-3, 2023, in NY Oppenheimer’s Private Company Symposium, taking place October 11, 2023, in NY 3rd Annual Needham Private Biotech […]

Events

Myeloid Therapeutics to Participate at Upcoming Investor Conferences

CAMBRIDGE, Mass., Aug. 31, 2023 /PRNewswire/ — Myeloid Therapeutics, Inc. (“Myeloid”), a clinical stage mRNA-immunotherapy company, today announced that it will participate in the following investor conferences: Citi’s 18th Annual BioPharma Conference, taking place September 5-7, 2023, in Boston, MA Management will participate in a fireside chat on September 6, 2023, at 11:20 am ET. […]

Events

Myeloid Therapeutics to Participate at SVB Securities Biopharma Company Connect Event

CAMBRIDGE, Mass, May 22, 2023 – Myeloid Therapeutics, Inc. (“Myeloid”), a clinical stage mRNA-immunotherapy company, today announced that it will participate in the SVB Securities Biopharma Company Connect event, taking place virtually May 24th- 25th, 2023. Myeloid management will participate in virtual one-on-one meetings with investors during the event. About Myeloid Therapeutics Myeloid Therapeutics is […]